help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0955
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odet, F.
Right arrow Articles by Le Magueresse-Battistoni, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odet, F.
Right arrow Articles by Le Magueresse-Battistoni, B.
Endocrinology Vol. 145, No. 3 1481-1489
Copyright © 2004 by The Endocrine Society

Evidence for Similar Expression of Protein C Inhibitor and the Urokinase-Type Plasminogen Activator System during Mouse Testis Development

Fanny Odet, Romain Guyot, Patrick Leduque and Brigitte Le Magueresse-Battistoni

Institut National de la Santé et de la Recherche Médicale, Unité 329, Hopital Debrousse, 69322 Lyon, France

Address all correspondence and requests for reprints to: Dr. B. Le Magueresse-Battistoni, Institut National de la Santé et de la Recherche Médicale, Unité 329, Hopital Debrousse, 29 rue Soeur Bouvier, 69322 Lyon Cedex 05, France. E-mail: lemagueresse{at}lyon.inserm.fr.

Plasminogen activators (PAs) and their inhibitors (PAIs) are predicted to be involved in the restructuring events that characterize the testis throughout development. We here demonstrate that PAI-3 or protein C (PC) inhibitor (PCI) was expressed in a sexually dimorphic fashion during mouse gonad genesis, whereas PAI-1 and -2 exhibited no sex differences. PCI transcripts accumulated rapidly in the male gonad, from 12.5 d postcoitum onward. Western blot and immunohistochemistry analyses confirmed that male, but not female, fetal gonads produced PCI, and that Leydig cells are the site of PCI synthesis. The occurrence of testicular target proteases for PCI, i.e. PC and urokinase- and tissue-type PA, was further tracked using RT-PCR, plasminogen zymography, and/or immunohistochemistry. PC and tissue-type PA showed no variation between sexes. By contrast, urokinase-type PA and its receptor (uPAR; which dictates the site and extent of proteolysis) exhibited sex differences from 13.5–14.5 d postcoitum. At that time, uPAR expression was restricted to Leydig cells. At earlier ages, uPAR was uniformly and widely distributed in the gonads of both sexes. In adult testes, PCI and uPAR immunoreactivities were also present in Leydig cells. In addition, PCI, PC, and uPAR had a germinal origin. Collectively, these results support the hypothesis that PCI may contribute to proteolysis equilibrium within the testis by acting in tandem with urokinase in Leydig cells and with PC and/or urokinase in spermatogenic cells. It will be important to determine how this role is linked to the phenotype of sterility reported elsewhere in male mice with pci deleted.




This article has been cited by other articles:


Home page
ReproductionHome page
S. Mazaud Guittot, A. Verot, F. Odet, M.-A. Chauvin, and B. le Magueresse-Battistoni
A comprehensive survey of the laminins and collagens type IV expressed in mouse Leydig cells and their regulation by LH/hCG
Reproduction, April 1, 2008; 135(4): 479 - 488.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. Le Magueresse-Battistoni
Serine proteases and serine protease inhibitors in testicular physiology: the plasminogen activation system
Reproduction, December 1, 2007; 134(6): 721 - 729.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Odet, A. Verot, and B. Le Magueresse-Battistoni
The Mouse Testis Is the Source of Various Serine Proteases and Serine Proteinase Inhibitors (SERPINs): Serine Proteases and SERPINs Identified in Leydig Cells Are under Gonadotropin Regulation
Endocrinology, September 1, 2006; 147(9): 4374 - 4383.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. Denolet, K. De Gendt, J. Allemeersch, K. Engelen, K. Marchal, P. Van Hummelen, K. A. L. Tan, R. M. Sharpe, P. T. K. Saunders, J. V. Swinnen, et al.
The Effect of a Sertoli Cell-Selective Knockout of the Androgen Receptor on Testicular Gene Expression in Prepubertal Mice
Mol. Endocrinol., February 1, 2006; 20(2): 321 - 334.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
R E. Ramy, A Verot, S Mazaud, F Odet, S Magre, and B Le Magueresse-Battistoni
Fibroblast growth factor (FGF) 2 and FGF9 mediate mesenchymal-epithelial interactions of peritubular and Sertoli cells in the rat testis
J. Endocrinol., October 1, 2005; 187(1): 135 - 147.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
M. D. Anway, M. D. Show, and B. R. Zirkin
Protein C Inhibitor Expression by Adult Rat Sertoli Cells: Effects of Testosterone Withdrawal and Replacement
J Androl, September 1, 2005; 26(5): 578 - 585.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society